InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Kaplan Gilla. Officer active across 2 companies, notably Avalo Therapeutics, Inc.. Aggregated, 6 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €267k. History available since 13 June 2024. The latest transaction was disclosed on 25 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
KAPLAN GILLA is a declarant and has 6 filings in total. Across the 6 sampled recent filings between 2024-06-18 and 2026-03-31, sales total EUR 266683 and the stated transaction nature is option exercise. She is a director of Tyra Biosciences, Inc. and Avalo Therapeutics, Inc.